+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Stem Cell Transplant"

From
From
Hematopoietic Stem Cell Transplantation - Pipeline Insight, 2024 - Product Thumbnail Image

Hematopoietic Stem Cell Transplantation - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
From
Global Stem Cell Therapy Market 2023-2027 - Product Thumbnail Image

Global Stem Cell Therapy Market 2023-2027

  • Report
  • August 2023
  • 166 Pages
  • Global
From
From
From
From
Global Graft Versus Host Disease (GvHD) Treatment Market - Product Thumbnail Image

Global Graft Versus Host Disease (GvHD) Treatment Market

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Global Stem Cells Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Global Stem Cells Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
Cancer Stem Cells: Technologies and Global Markets to 2026 - Product Thumbnail Image

Cancer Stem Cells: Technologies and Global Markets to 2026

  • Report
  • December 2021
  • 206 Pages
  • Global
From
From
Loading Indicator

The Stem Cell Transplant market is a subset of the larger stem cell industry. It involves the use of stem cells to treat a variety of diseases and conditions, including cancer, blood disorders, and genetic diseases. Stem cell transplants are used to replace damaged or diseased cells with healthy ones, and can be used to treat a variety of conditions. The stem cell transplant market is a rapidly growing field, with new treatments and technologies being developed and tested. Companies in the market are focused on developing and commercializing stem cell therapies, as well as providing services related to stem cell transplantation. These companies include Celgene, Novartis, and Osiris Therapeutics. Additionally, there are a number of smaller companies that are focused on developing and commercializing stem cell therapies, such as Athersys, Inc., and Pluristem Therapeutics. Show Less Read more